BioNexus Gene Lab Cash Flow Statement (2018-2025) | BGLC

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
0.34M0.03M0.30M0.12M0.02M-0.14M-0.08M-0.15M-0.04M-0.29M-2.61M0.35M-0.06M0.20M-1.35M-0.34M-0.62M-0.62M-0.71M-1.04M
Depreciation and Depletion (Quarter)
0.01M0.04M0.02M0.02M0.02M0.02M0.02M0.02M0.02M-0.02M0.06M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M
Share-based Compensation (Quarter)
-0.09M0.79M
Deferred Taxes (Quarter)
0.00M0.02M
Gains from Investment Securities (Quarter)
0.30M0.08M-0.47M0.61M-0.07M0.20M-0.29M0.01M-0.04M0.03M0.51M-0.01M-0.01M-0.01M0.53M-0.00M-0.01M0.02M-0.02M
Asset Writedowns and Impairment (Quarter)
97.00-0.00M0.00M-0.12M0.18M0.06M
Non-cash Items (Quarter)
0.04M-0.06M0.00M-0.09M-0.05M-1.01M-0.79M-0.04M-0.34M-1.46M-0.51M
Cash from Operations (Quarter)
0.12M-0.91M0.32M0.48M-0.04M-0.20M0.31M0.48M-0.12M-0.02M-0.90M-0.78M-0.04M-0.67M-1.60M0.22M-0.82M-0.74M-1.24M0.96M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Amortization of Deferred Charges (Quarter)
0.00M0.00M
Depreciation & Amortization (CF) (Quarter)
0.01M0.04M0.02M0.02M0.02M0.02M0.02M0.02M0.02M-0.02M0.06M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.03M0.03M
Change in Working Capital
Change in Receivables (Quarter)
-0.40M0.51M-0.31M0.78M-0.33M-0.20M-0.11M1.18M-0.34M-0.02M-0.15M1.16M-0.11M0.12M-0.15M0.00M-0.11M0.48M-0.21M-0.94M
Change in Inventory (Quarter)
0.29M-0.82M0.22M-0.03M0.13M-0.14M-0.42M0.97M-0.08M0.27M-0.06M-0.29M0.06M-0.17M0.36M-452.000.21M-0.38M-0.21M-0.33M
Change in Account Payables (Quarter)
-0.30M-0.54M0.05M-0.39M-0.21M-0.43M-0.13M0.65M-0.43M0.32M-0.25M-0.02M0.06M-0.51M0.20M0.46M-0.32M0.20M-1.11M-0.16M
Change in Taxes (Quarter)
0.03M0.01M0.04M-0.02M0.03M0.03M0.09M-0.14M-0.00M-0.03M0.00M-0.02M-0.01M0.06M-0.09M
Other Working Capital Changes (Quarter)
-0.01M0.01M-0.02M-0.08M0.07M-0.01M-0.10M-0.00M-0.01M0.10M-0.01M-0.01M-0.01M-0.00M-0.02M-0.07M0.06M-0.01M-0.01M
Investing Activities
Capital Expenditures (Quarter)
807.00666.00410.000.00M0.03M-0.03M0.04M0.02M102.000.04M0.11M937.000.02M0.00M0.20M0.00M0.01M0.02M0.01M977.00
Sales of Property, Plant and Equipment (Quarter)
Divestments (Quarter)
0.01M0.01M0.01M0.02M0.08M0.01M0.01M0.20M0.57M0.01M
Change in Acquisitions & Divestments (Quarter)
-52.00-22.000.03M-708.000.21M0.09M0.20M0.57M
Cash from Investing Activities (Quarter)
-0.30M-0.06M-0.06M-0.08M-0.20M-0.22M0.02M-0.05M-0.01M-0.00M-0.36M-1.43M0.00M0.06M-0.20M0.55M-0.02M-0.03M0.99M-0.01M
Financing Activities
Cash from Financing Activities (Quarter)
-0.01M-0.01M-0.01M-0.00M0.11M-0.00M-0.00M-0.00M-0.00M5.75M0.53M0.03M0.18M-0.06M-0.14M-860.00-0.00M0.03M0.27M
Dividend Payments
Dividends Paid - Common (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Additional items
Exchange Rate Effect (Quarter)
-0.03M0.02M-0.04M-0.20M-0.20M0.23M-0.02M-0.19M-0.10M0.05M-0.07M-0.04M0.57M-0.41M0.04M0.22M0.03M-0.09M
Change in Cash (Quarter)
-0.31M-0.99M0.22M0.42M-0.28M-0.50M1.45M-0.67M-0.15M-0.21M4.39M-1.63M-0.08M-0.48M-1.30M0.22M-0.80M-0.55M-0.18M1.13M
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)
0.11M-0.91M0.32M0.48M-0.07M-0.16M0.27M0.46M-0.12M-0.07M-1.01M-0.78M-0.06M-0.67M-1.80M0.22M-0.83M-0.76M-1.24M0.96M
Net Cash Flow (Quarter)
-0.19M-0.97M0.25M0.40M-0.23M-0.31M0.33M0.42M-0.12M-0.03M4.49M-1.68M-0.01M-0.43M-1.86M0.63M-0.84M-0.77M-0.21M1.22M